Cytokine signaling in chimeric antigen receptor T-cell therapy.

Authors:
Kagoya Y.

Journal:
Int Immunol

Publication Year: 2024

DOI:
10.1093/intimm/dxad033

PMCID:
PMC10872714

PMID:
37591521

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int Immunol

Abbreviation: Int Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Peripheral helper T cells, mavericks of peripheral immune responses.
Yoshitomi H. (2024) - Transparency Score: 3/6
Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cel…
Kawamoto H; Masuda K. (2024) - Transparency Score: 3/6
The proliferative activity levels of each immune cell population evaluated by mass cytometry are li…
Kajihara A; Morita T; Kato Y and 13 more (2023) - Transparency Score: 3/6
Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T ce…
Tatsuguchi T; Uruno T; Sugiura Y and 16 more (2022) - Transparency Score: 3/6
Control of inflammation using non-invasive neuromodulation: past, present and promise.
Tynan A; Brines M; Chavan SS. (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest statement. Y. Kagoya received a commercial research grant from Takara Bio."

Evidence found in paper:

"Funding This work was supported by the Japan Agency for Medical Research and Development (AMED) under grant numbers JP22bm0704066, JP22ym0126072, and JP22ama221303 (Y.K.); a Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 23H02779; the Takeda Science Foundation; and Multiple myeloma Research Grant from Myeloma Patients and Families."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025